Organised mammography screening reduces breast cancer mortality: A cohort study from Finland

International Journal of Cancer

Volumn 122, Issue 3, 2008, Pages 614-619

  Sarkeala, Tytti ^a   Heinävaara, Sirpa ^a,b   Anttila, Ahti ^a  

^a FINNISH CANCER REGISTRY   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Breast cancer; Effectiveness; Epidemiology; Mammography; Screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; COHORT ANALYSIS; FEMALE; FINLAND; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

AGED; BREAST NEOPLASMS; COHORT STUDIES; DENMARK; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; SURVIVAL RATE; TIME FACTORS;

EID: 37349033919     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23070     Document Type: Article

References (25)

1. International Agency for Research on Cancer, IARC. IARC handbooks of cancer prevention, Vol. 7. Breast cancer screening. Oxford: Oxford University Press, 2002.229 p.
2. The Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from the organised service screening with mammography: Part 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 2006;15:45-51.
3. The Swedish Organised Service Screening Evaluation Group. Reduction in breast cancer mortality from the organised service screening with mammography: Part 2. Validation with alternative analytic methods. Cancer Epidemiol Biomarkers Prev 2006;15:52-6.
4. Olsen AH, Njor SH, Vejborg I, Schwartz W, Dalgaard P, Jensen M-B, Brix Tange U, Blichert-Toft M, Rank F, Mouridsen H, Lynge E. Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ 2005;330:220.
5. Hakama M, Pukkala E, Kallio M, Godenhjelm K, Svinhufvud U. Effectiveness of screening for breast cancer in women under 50 years at entry: the Kotka pilot project in Finland. Int J Cancer 1995;63:55-7.
6. Hakama M, Pukkala E, Heikkilä M, Kallio M. Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ 1997;314:864-7.
7. Sarkeala T, Anttila A, Forsman H, Luostarinen T, Saarenmaa I, Hakama M. Process indicators from ten centres in the Finnish breast cancer screening programme from 1991 to 2000. Eur J Cancer 2004;40:2116-25.
8. Sarkeala T, Hakama M, Saarenmaa I, Hakulinen T, Forsman H, Anttila A. Episode sensitivity in association with process indicators in the Finnish breast cancer screening program. Int J Cancer 2006;118:174-9.
9. Lynge E, Olsen AH, Fracheboud J, Patnick J. Reporting of performance indicators of mammography screening in Europe. Eur J Cancer Prev 2003;12:213-22.
10. Miller AB. Is mammography screening for breast cancer really not justifiable? Recent Results Cancer Res 2003;163:115-28.
11. Olsen O, Gotzsche P. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358:1340-42.
12. Gotzche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Libr 2006;4:60.
13. Otto SJ, Fracheboud J, Looman CWN, Broeders MJM, Boer R, Hendriks JH, Verbeek AL, de Koning HJ. Initiation of population-based mammography screening in Dutch municipalities and effect of breast cancer mortality: a systemic review. Lancet 2003;361:1411-17.
14. Anttila A, Koskela J, Hakama M. Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen 2002;9:153-8.
15. Parvinen I, Helenius H, Pylkkänen L, Anttila A, Immonen- Räihä P, Kauhava L, Räsänen O, Klemi PJ. Service screening mammography reduces breast cancer mortality among elderly women in Turku. J Med Screen 2006;13:34-40.
16. Cuzick J, Edwards R, Segnan N. Adjusting for non-compliance and contamination in randomised clinical trials. Stat Med 1997;16:1017-29.
17. Botha JL, Bray F, Sankila R, Parkin DM. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 2003;39:1718-29.
18. Finnish Cancer Registry. Cancer in Finland 2002 and 2003. Helsinki: Cancer Society of Finland, 2005.88 p. Publication No. 66.
19. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353:1784-92.
20. Duffy SW, McCann J, Godward S, Gabe R, Warwick J. Some issues in screening for breast and other cancers. J Med Screen 2006;13 (Suppl. 1):28-34.
21. Aro A, de Koning HJ, Absetz P, Schreck M. Psychosocial predictors of first attendance for organised mammography screening. J Med Screen 1999;6:82-8.
22. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002;359:1903-8.
23. Fracheboud J, de Koning HJ, Beemsterboer PM, Boer R, Hendriks JH, Verbeek AL, van Ineveld BM, de Bruyn AE, van der Maas PJ. Nationwide breast cancer screening programme in the Netherlands. Results of initial and subsequent screening 1990-1995. Int J Cancer 1998;75:694-8.
24. Fracheboud J, de Koning HJ, Boer R, et al. Nationwide breast cancer screening programme fully implemented in the Netherlands. Breast 2001;10:6-10.
25. Fracheboud J, Otto SJ, van Dijk JA, Breeders MJ, Verbeek AL, de Koning H. Decreased rates of advanced breast cancers due to mammography screening in the Netherlands. Br J Cancer 2004;91:861-7.